将基于证据的兴奋剂治疗带到永久支持性住房
K Michelle Peavy1, Katharine Palmer1, Emily Leickly1
1Promoting Research Initiatives in Substance Use and Mental Health (PRISM) Collaborative, Department of Community and Behavioral Health, Elson S. Floyd College of Medicine, Washington State University, Spokane, Washington State, USA.
对兴奋剂使用障碍的应急管理 (CM) 在永久支持性住房 (PSH) 设置中成功实施. 这项研究强调了将临床干预整合到非临床环境中的关键因素.
科学领域:
- 成 药物 药物 药物 药物
- 实施科学 实施科学
- 公共卫生 公共卫生
背景情况:
- 应急管理 (CM) 对于兴奋剂使用障碍是有效的,但在临床环境之外很少使用.
- 永久支持性住房 (PSH) 提供了一个独特的环境,可以为弱势群体提供干预措施.
- 将基于证据的实践整合到非传统环境中,带来了实施挑战.
研究的目的:
- 在PSH环境中检查一种以兴奋剂为重点的CM协议的实施过程.
- 确定CM与PSH整合所需的障碍,促进者和适应措施.
- 为在非临床环境中实施临床干预提供见解.
主要方法:
- 从16个月的执行会议会议会议记录的专题分析.
- 定性数据收集和分析以确定实施主题.
- 记录在PSH设置中启动CM的过程.
主要成果:
- 四个主要主题出现了:哲学对齐,障碍/促进者,适应/支持和组织变化.
- 尽管面临诸如空间限制和参与困难等挑战,但28名居民参加了CM.
- 成功实施需要持续,高触摸技术援助和早期模型开发.
结论:
- 在PSH中实施CM是可行的,需要仔细规划和持续支持.
- 了解组织格局和促进协调是成功的关键.
- 学习的经验可以为更广泛地将临床干预纳入社区环境提供信息.
更多相关视频
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
10:28Assessment of Cocaine-induced Behavioral Sensitization and Conditioned Place Preference in Mice
Published on: February 18, 2016
相关概念视频
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
